Carbohydrates

Strong organic synthesis capabilities enabling the development of diverse and complex pharmaceutical molecules with quality at every stage.

Established achiral chemistry capabilities supporting diverse pharmaceutical development and manufacturing requirements.

Ampoule-based injectable solutions supported by robust manufacturing capabilities and consistent quality.

Innovative drug delivery formats designed to support convenience, ease of use and patient-centric care.

Expertise in azido and nitroso impurity characterization, supporting comprehensive quality and analytical requirements for pharmaceutical development.

A broad capsule portfolio combining quality, consistency and reliable pharmaceutical manufacturing.

Specialized depot injection capabilities supporting long-acting therapeutic solutions.

Dedicated capabilities for genotoxic impurity characterization, supporting pharmaceutical partners in their quality and development requirements.

A range of granule-based formulations designed to support convenient and versatile drug delivery.

Specialized expertise in heterocyclic chemistry, supporting a broad range of pharmaceutical molecules and development needs.

Growing capabilities in hormone products, supported by strong pharmaceutical expertise, quality-focused processes and reliable supply for global partners.

Specialized metal chemistry capabilities combining chemistry expertise, quality and a strong focus on dependable solutions for pharmaceutical partners.

MSN Group is one of the fastest-growing, research-based and fully integrated pharmaceutical companies based out of Hyderabad, India. It was founded in the year 2003 with a mission to make high-quality medicines affordable and accessible to the world. The organization presently has 24 state-of-the-art manufacturing facilities (16 API and 8 Finished Dosage Facilities) established across India and USA. The group has an integrated R&D centre that facilitates the research of both API and Finished Dosages under one roof, enabling the organization to introduce new and affordable therapies in global markets swiftly.